Teljane was established in July 2021 in Shanghai, China. The company is dedicated to the R&D and industrialization of innovative medical devices in the field of glucose management. With a core team composed of renowned domestic and international experts, the company focuses on high-sensitivity, long-lifespan biosensor technology that has reached a globally leading standard.

At Teljane, research and technology drive our innovation. Our R&D team combines biochemistry, microelectronics, materials science, and algorithm engineering to develop next-generation biosensors with outstanding sensitivity and long lifespan. We refine sensor chemistry for durability and stability, while applying advanced data analytics and algorithms to improve accuracy and prediction. With dedicated labs in Shanghai and Silicon Valley, Teljane is building a strong foundation for multi-molecule monitoring that extends beyond glucose to ketones, lactate, and uric acid, shaping the future of chronic disease management.